Last reviewed · How we verify
NCT03780205
Bilateral and Unilateral Amblyopia Treatment Study
trial testing Prescription glasses for bilateral amblyopia in Amblyopia in 1 participant. Terminated before completion.
7 July 2020
Quick facts
| Lead sponsor | Salus University |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 20 March 2019 |
| Primary completion | 7 July 2020 |
| Estimated completion | 7 July 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Prescription glasses for bilateral amblyopia
- Prescription glasses for unilateral amblyopia
Conditions studied
- Amblyopia — all drugs for Amblyopia →
Sponsor
Salus University
Who can join
Adults 3 to 10, any sex, with Amblyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to \<10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spectacle correction alone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03780205
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amblyopia
Currently open trials in the same condition.
- NCT07323953 — Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia in Children · NA · recruiting
- NCT07281742 — Amblyopia Treatment for Children Aged 8 to 12 Years · NA · recruiting
- NCT07417046 — Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopi · NA · recruiting
- NCT06524882 — Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age · Phase 3 · recruiting
- NCT06380517 — Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age · Phase 3 · recruiting
Other Salus University trials
Trials by the same sponsor.
- NCT06848673 — Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI · Phase 2 · not yet recruiting
- NCT07282691 — Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders · recruiting
- NCT05825248 — Comparing Two Protocols to Improve Reflex Integration and Functional Performance · NA · unknown
- NCT05242575 — The Influence of Immersive Virtual Field Trips on Academic Vocabulary · NA · completed
- NCT04185324 — Efficacy of an Intervention to Teach Zippering: A Two-Group Control Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03780205 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salus University
- Last refreshed: 31 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03780205.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing